Global Mental Disorders Drugs Market Insights, Forecast to 2029
Table of Contents1 Study Coverage
1.1 Mental Disorders Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Mental Disorders Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Drugs for Schizophrenia
1.2.3 Antidepressants
1.2.4 Antipsychotics
1.2.5 Anxiolytics
1.2.6 Drugs for the Treatment of Substance and Alcohol Addiction
1.2.7 Drugs for Childhood and Adolescent Mental Illness
1.2.8 Drugs to Treat Cognitive Disorders
1.2.9 Sleep Disorders
1.2.10 Others
1.3 Market by Application
1.3.1 Global Mental Disorders Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Children
1.3.3 Adolescents
1.3.4 Adults
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Mental Disorders Drugs Sales Estimates and Forecasts 2018-2029
2.2 Global Mental Disorders Drugs Revenue by Region
2.2.1 Global Mental Disorders Drugs Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Mental Disorders Drugs Revenue by Region (2018-2023)
2.2.3 Global Mental Disorders Drugs Revenue by Region (2024-2029)
2.2.4 Global Mental Disorders Drugs Revenue Market Share by Region (2018-2029)
2.3 Global Mental Disorders Drugs Sales Estimates and Forecasts 2018-2029
2.4 Global Mental Disorders Drugs Sales by Region
2.4.1 Global Mental Disorders Drugs Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Mental Disorders Drugs Sales by Region (2018-2023)
2.4.3 Global Mental Disorders Drugs Sales by Region (2024-2029)
2.4.4 Global Mental Disorders Drugs Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Mental Disorders Drugs Sales by Manufacturers
3.1.1 Global Mental Disorders Drugs Sales by Manufacturers (2018-2023)
3.1.2 Global Mental Disorders Drugs Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Mental Disorders Drugs in 2022
3.2 Global Mental Disorders Drugs Revenue by Manufacturers
3.2.1 Global Mental Disorders Drugs Revenue by Manufacturers (2018-2023)
3.2.2 Global Mental Disorders Drugs Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Mental Disorders Drugs Revenue in 2022
3.3 Global Key Players of Mental Disorders Drugs, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Mental Disorders Drugs Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Mental Disorders Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Mental Disorders Drugs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Mental Disorders Drugs, Product Offered and Application
3.8 Global Key Manufacturers of Mental Disorders Drugs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Mental Disorders Drugs Sales by Type
4.1.1 Global Mental Disorders Drugs Historical Sales by Type (2018-2023)
4.1.2 Global Mental Disorders Drugs Forecasted Sales by Type (2024-2029)
4.1.3 Global Mental Disorders Drugs Sales Market Share by Type (2018-2029)
4.2 Global Mental Disorders Drugs Revenue by Type
4.2.1 Global Mental Disorders Drugs Historical Revenue by Type (2018-2023)
4.2.2 Global Mental Disorders Drugs Forecasted Revenue by Type (2024-2029)
4.2.3 Global Mental Disorders Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Mental Disorders Drugs Price by Type
4.3.1 Global Mental Disorders Drugs Price by Type (2018-2023)
4.3.2 Global Mental Disorders Drugs Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Mental Disorders Drugs Sales by Application
5.1.1 Global Mental Disorders Drugs Historical Sales by Application (2018-2023)
5.1.2 Global Mental Disorders Drugs Forecasted Sales by Application (2024-2029)
5.1.3 Global Mental Disorders Drugs Sales Market Share by Application (2018-2029)
5.2 Global Mental Disorders Drugs Revenue by Application
5.2.1 Global Mental Disorders Drugs Historical Revenue by Application (2018-2023)
5.2.2 Global Mental Disorders Drugs Forecasted Revenue by Application (2024-2029)
5.2.3 Global Mental Disorders Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Mental Disorders Drugs Price by Application
5.3.1 Global Mental Disorders Drugs Price by Application (2018-2023)
5.3.2 Global Mental Disorders Drugs Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Mental Disorders Drugs Market Size by Type
6.1.1 US & Canada Mental Disorders Drugs Sales by Type (2018-2029)
6.1.2 US & Canada Mental Disorders Drugs Revenue by Type (2018-2029)
6.2 US & Canada Mental Disorders Drugs Market Size by Application
6.2.1 US & Canada Mental Disorders Drugs Sales by Application (2018-2029)
6.2.2 US & Canada Mental Disorders Drugs Revenue by Application (2018-2029)
6.3 US & Canada Mental Disorders Drugs Market Size by Country
6.3.1 US & Canada Mental Disorders Drugs Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Mental Disorders Drugs Sales by Country (2018-2029)
6.3.3 US & Canada Mental Disorders Drugs Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Mental Disorders Drugs Market Size by Type
7.1.1 Europe Mental Disorders Drugs Sales by Type (2018-2029)
7.1.2 Europe Mental Disorders Drugs Revenue by Type (2018-2029)
7.2 Europe Mental Disorders Drugs Market Size by Application
7.2.1 Europe Mental Disorders Drugs Sales by Application (2018-2029)
7.2.2 Europe Mental Disorders Drugs Revenue by Application (2018-2029)
7.3 Europe Mental Disorders Drugs Market Size by Country
7.3.1 Europe Mental Disorders Drugs Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Mental Disorders Drugs Sales by Country (2018-2029)
7.3.3 Europe Mental Disorders Drugs Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Mental Disorders Drugs Market Size
8.1.1 China Mental Disorders Drugs Sales (2018-2029)
8.1.2 China Mental Disorders Drugs Revenue (2018-2029)
8.2 China Mental Disorders Drugs Market Size by Application
8.2.1 China Mental Disorders Drugs Sales by Application (2018-2029)
8.2.2 China Mental Disorders Drugs Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Mental Disorders Drugs Market Size by Type
9.1.1 Asia Mental Disorders Drugs Sales by Type (2018-2029)
9.1.2 Asia Mental Disorders Drugs Revenue by Type (2018-2029)
9.2 Asia Mental Disorders Drugs Market Size by Application
9.2.1 Asia Mental Disorders Drugs Sales by Application (2018-2029)
9.2.2 Asia Mental Disorders Drugs Revenue by Application (2018-2029)
9.3 Asia Mental Disorders Drugs Sales by Region
9.3.1 Asia Mental Disorders Drugs Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Mental Disorders Drugs Revenue by Region (2018-2029)
9.3.3 Asia Mental Disorders Drugs Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Mental Disorders Drugs Market Size by Type
10.1.1 Middle East, Africa and Latin America Mental Disorders Drugs Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Mental Disorders Drugs Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Mental Disorders Drugs Market Size by Application
10.2.1 Middle East, Africa and Latin America Mental Disorders Drugs Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Mental Disorders Drugs Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Mental Disorders Drugs Sales by Country
10.3.1 Middle East, Africa and Latin America Mental Disorders Drugs Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Mental Disorders Drugs Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Mental Disorders Drugs Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Information
11.1.2 Johnson & Johnson Overview
11.1.3 Johnson & Johnson Mental Disorders Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Johnson & Johnson Mental Disorders Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Johnson & Johnson Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Mental Disorders Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Pfizer Mental Disorders Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Company Information
11.3.2 Eli Lilly Overview
11.3.3 Eli Lilly Mental Disorders Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Eli Lilly Mental Disorders Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Eli Lilly Recent Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Information
11.4.2 GlaxoSmithKline Overview
11.4.3 GlaxoSmithKline Mental Disorders Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 GlaxoSmithKline Mental Disorders Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 GlaxoSmithKline Recent Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Company Information
11.5.2 AstraZeneca Overview
11.5.3 AstraZeneca Mental Disorders Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 AstraZeneca Mental Disorders Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 AstraZeneca Recent Developments
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Information
11.6.2 Bristol-Myers Squibb Overview
11.6.3 Bristol-Myers Squibb Mental Disorders Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Bristol-Myers Squibb Mental Disorders Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Bristol-Myers Squibb Recent Developments
11.7 Abbott Laboratories
11.7.1 Abbott Laboratories Company Information
11.7.2 Abbott Laboratories Overview
11.7.3 Abbott Laboratories Mental Disorders Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Abbott Laboratories Mental Disorders Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Abbott Laboratories Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Mental Disorders Drugs Industry Chain Analysis
12.2 Mental Disorders Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Mental Disorders Drugs Production Mode & Process
12.4 Mental Disorders Drugs Sales and Marketing
12.4.1 Mental Disorders Drugs Sales Channels
12.4.2 Mental Disorders Drugs Distributors
12.5 Mental Disorders Drugs Customers
13 Market Dynamics
13.1 Mental Disorders Drugs Industry Trends
13.2 Mental Disorders Drugs Market Drivers
13.3 Mental Disorders Drugs Market Challenges
13.4 Mental Disorders Drugs Market Restraints
14 Key Findings in The Global Mental Disorders Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of TablesTable 1. Global Mental Disorders Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Drugs for Schizophrenia
Table 3. Major Manufacturers of Antidepressants
Table 4. Major Manufacturers of Antipsychotics
Table 5. Major Manufacturers of Anxiolytics
Table 6. Major Manufacturers of Drugs for the Treatment of Substance and Alcohol Addiction
Table 7. Major Manufacturers of Drugs for Childhood and Adolescent Mental Illness
Table 8. Major Manufacturers of Drugs to Treat Cognitive Disorders
Table 9. Major Manufacturers of Sleep Disorders
Table 10. Major Manufacturers of Others
Table 11. Global Mental Disorders Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global Mental Disorders Drugs Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global Mental Disorders Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 14. Global Mental Disorders Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 15. Global Mental Disorders Drugs Revenue Market Share by Region (2018-2023)
Table 16. Global Mental Disorders Drugs Revenue Market Share by Region (2024-2029)
Table 17. Global Mental Disorders Drugs Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 18. Global Mental Disorders Drugs Sales by Region (2018-2023) & (K Units)
Table 19. Global Mental Disorders Drugs Sales by Region (2024-2029) & (K Units)
Table 20. Global Mental Disorders Drugs Sales Market Share by Region (2018-2023)
Table 21. Global Mental Disorders Drugs Sales Market Share by Region (2024-2029)
Table 22. Global Mental Disorders Drugs Sales by Manufacturers (2018-2023) & (K Units)
Table 23. Global Mental Disorders Drugs Sales Share by Manufacturers (2018-2023)
Table 24. Global Mental Disorders Drugs Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 25. Global Mental Disorders Drugs Revenue Share by Manufacturers (2018-2023)
Table 26. Global Key Players of Mental Disorders Drugs, Industry Ranking, 2021 VS 2022 VS 2023
Table 27. Mental Disorders Drugs Price by Manufacturers 2018-2023 (USD/Pcs)
Table 28. Global Mental Disorders Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 29. Global Mental Disorders Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mental Disorders Drugs as of 2022)
Table 30. Global Key Manufacturers of Mental Disorders Drugs, Manufacturing Base Distribution and Headquarters
Table 31. Global Key Manufacturers of Mental Disorders Drugs, Product Offered and Application
Table 32. Global Key Manufacturers of Mental Disorders Drugs, Date of Enter into This Industry
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Mental Disorders Drugs Sales by Type (2018-2023) & (K Units)
Table 35. Global Mental Disorders Drugs Sales by Type (2024-2029) & (K Units)
Table 36. Global Mental Disorders Drugs Sales Share by Type (2018-2023)
Table 37. Global Mental Disorders Drugs Sales Share by Type (2024-2029)
Table 38. Global Mental Disorders Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 39. Global Mental Disorders Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 40. Global Mental Disorders Drugs Revenue Share by Type (2018-2023)
Table 41. Global Mental Disorders Drugs Revenue Share by Type (2024-2029)
Table 42. Mental Disorders Drugs Price by Type (2018-2023) & (USD/Pcs)
Table 43. Global Mental Disorders Drugs Price Forecast by Type (2024-2029) & (USD/Pcs)
Table 44. Global Mental Disorders Drugs Sales by Application (2018-2023) & (K Units)
Table 45. Global Mental Disorders Drugs Sales by Application (2024-2029) & (K Units)
Table 46. Global Mental Disorders Drugs Sales Share by Application (2018-2023)
Table 47. Global Mental Disorders Drugs Sales Share by Application (2024-2029)
Table 48. Global Mental Disorders Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 49. Global Mental Disorders Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 50. Global Mental Disorders Drugs Revenue Share by Application (2018-2023)
Table 51. Global Mental Disorders Drugs Revenue Share by Application (2024-2029)
Table 52. Mental Disorders Drugs Price by Application (2018-2023) & (USD/Pcs)
Table 53. Global Mental Disorders Drugs Price Forecast by Application (2024-2029) & (USD/Pcs)
Table 54. US & Canada Mental Disorders Drugs Sales by Type (2018-2023) & (K Units)
Table 55. US & Canada Mental Disorders Drugs Sales by Type (2024-2029) & (K Units)
Table 56. US & Canada Mental Disorders Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 57. US & Canada Mental Disorders Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 58. US & Canada Mental Disorders Drugs Sales by Application (2018-2023) & (K Units)
Table 59. US & Canada Mental Disorders Drugs Sales by Application (2024-2029) & (K Units)
Table 60. US & Canada Mental Disorders Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 61. US & Canada Mental Disorders Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 62. US & Canada Mental Disorders Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 63. US & Canada Mental Disorders Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 64. US & Canada Mental Disorders Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 65. US & Canada Mental Disorders Drugs Sales by Country (2018-2023) & (K Units)
Table 66. US & Canada Mental Disorders Drugs Sales by Country (2024-2029) & (K Units)
Table 67. Europe Mental Disorders Drugs Sales by Type (2018-2023) & (K Units)
Table 68. Europe Mental Disorders Drugs Sales by Type (2024-2029) & (K Units)
Table 69. Europe Mental Disorders Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 70. Europe Mental Disorders Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 71. Europe Mental Disorders Drugs Sales by Application (2018-2023) & (K Units)
Table 72. Europe Mental Disorders Drugs Sales by Application (2024-2029) & (K Units)
Table 73. Europe Mental Disorders Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 74. Europe Mental Disorders Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 75. Europe Mental Disorders Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 76. Europe Mental Disorders Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 77. Europe Mental Disorders Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 78. Europe Mental Disorders Drugs Sales by Country (2018-2023) & (K Units)
Table 79. Europe Mental Disorders Drugs Sales by Country (2024-2029) & (K Units)
Table 80. China Mental Disorders Drugs Sales by Type (2018-2023) & (K Units)
Table 81. China Mental Disorders Drugs Sales by Type (2024-2029) & (K Units)
Table 82. China Mental Disorders Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 83. China Mental Disorders Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 84. China Mental Disorders Drugs Sales by Application (2018-2023) & (K Units)
Table 85. China Mental Disorders Drugs Sales by Application (2024-2029) & (K Units)
Table 86. China Mental Disorders Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 87. China Mental Disorders Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 88. Asia Mental Disorders Drugs Sales by Type (2018-2023) & (K Units)
Table 89. Asia Mental Disorders Drugs Sales by Type (2024-2029) & (K Units)
Table 90. Asia Mental Disorders Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 91. Asia Mental Disorders Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 92. Asia Mental Disorders Drugs Sales by Application (2018-2023) & (K Units)
Table 93. Asia Mental Disorders Drugs Sales by Application (2024-2029) & (K Units)
Table 94. Asia Mental Disorders Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 95. Asia Mental Disorders Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 96. Asia Mental Disorders Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 97. Asia Mental Disorders Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 98. Asia Mental Disorders Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 99. Asia Mental Disorders Drugs Sales by Region (2018-2023) & (K Units)
Table 100. Asia Mental Disorders Drugs Sales by Region (2024-2029) & (K Units)
Table 101. Middle East, Africa and Latin America Mental Disorders Drugs Sales by Type (2018-2023) & (K Units)
Table 102. Middle East, Africa and Latin America Mental Disorders Drugs Sales by Type (2024-2029) & (K Units)
Table 103. Middle East, Africa and Latin America Mental Disorders Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 104. Middle East, Africa and Latin America Mental Disorders Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Mental Disorders Drugs Sales by Application (2018-2023) & (K Units)
Table 106. Middle East, Africa and Latin America Mental Disorders Drugs Sales by Application (2024-2029) & (K Units)
Table 107. Middle East, Africa and Latin America Mental Disorders Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 108. Middle East, Africa and Latin America Mental Disorders Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 109. Middle East, Africa and Latin America Mental Disorders Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 110. Middle East, Africa and Latin America Mental Disorders Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 111. Middle East, Africa and Latin America Mental Disorders Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 112. Middle East, Africa and Latin America Mental Disorders Drugs Sales by Country (2018-2023) & (K Units)
Table 113. Middle East, Africa and Latin America Mental Disorders Drugs Sales by Country (2024-2029) & (K Units)
Table 114. Johnson & Johnson Company Information
Table 115. Johnson & Johnson Description and Major Businesses
Table 116. Johnson & Johnson Mental Disorders Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 117. Johnson & Johnson Mental Disorders Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Johnson & Johnson Recent Developments
Table 119. Pfizer Company Information
Table 120. Pfizer Description and Major Businesses
Table 121. Pfizer Mental Disorders Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 122. Pfizer Mental Disorders Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Pfizer Recent Developments
Table 124. Eli Lilly Company Information
Table 125. Eli Lilly Description and Major Businesses
Table 126. Eli Lilly Mental Disorders Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 127. Eli Lilly Mental Disorders Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Eli Lilly Recent Developments
Table 129. GlaxoSmithKline Company Information
Table 130. GlaxoSmithKline Description and Major Businesses
Table 131. GlaxoSmithKline Mental Disorders Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 132. GlaxoSmithKline Mental Disorders Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. GlaxoSmithKline Recent Developments
Table 134. AstraZeneca Company Information
Table 135. AstraZeneca Description and Major Businesses
Table 136. AstraZeneca Mental Disorders Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 137. AstraZeneca Mental Disorders Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. AstraZeneca Recent Developments
Table 139. Bristol-Myers Squibb Company Information
Table 140. Bristol-Myers Squibb Description and Major Businesses
Table 141. Bristol-Myers Squibb Mental Disorders Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 142. Bristol-Myers Squibb Mental Disorders Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Bristol-Myers Squibb Recent Developments
Table 144. Abbott Laboratories Company Information
Table 145. Abbott Laboratories Description and Major Businesses
Table 146. Abbott Laboratories Mental Disorders Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 147. Abbott Laboratories Mental Disorders Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Abbott Laboratories Recent Developments
Table 149. Key Raw Materials Lists
Table 150. Raw Materials Key Suppliers Lists
Table 151. Mental Disorders Drugs Distributors List
Table 152. Mental Disorders Drugs Customers List
Table 153. Mental Disorders Drugs Market Trends
Table 154. Mental Disorders Drugs Market Drivers
Table 155. Mental Disorders Drugs Market Challenges
Table 156. Mental Disorders Drugs Market Restraints
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of FiguresFigure 1. Mental Disorders Drugs Product Picture
Figure 2. Global Mental Disorders Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Mental Disorders Drugs Market Share by Type in 2022 & 2029
Figure 4. Drugs for Schizophrenia Product Picture
Figure 5. Antidepressants Product Picture
Figure 6. Antipsychotics Product Picture
Figure 7. Anxiolytics Product Picture
Figure 8. Drugs for the Treatment of Substance and Alcohol Addiction Product Picture
Figure 9. Drugs for Childhood and Adolescent Mental Illness Product Picture
Figure 10. Drugs to Treat Cognitive Disorders Product Picture
Figure 11. Sleep Disorders Product Picture
Figure 12. Others Product Picture
Figure 13. Global Mental Disorders Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 14. Global Mental Disorders Drugs Market Share by Application in 2022 & 2029
Figure 15. Children
Figure 16. Adolescents
Figure 17. Adults
Figure 18. Mental Disorders Drugs Report Years Considered
Figure 19. Global Mental Disorders Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 20. Global Mental Disorders Drugs Revenue 2018-2029 (US$ Million)
Figure 21. Global Mental Disorders Drugs Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 22. Global Mental Disorders Drugs Revenue Market Share by Region (2018-2029)
Figure 23. Global Mental Disorders Drugs Sales 2018-2029 ((K Units)
Figure 24. Global Mental Disorders Drugs Sales Market Share by Region (2018-2029)
Figure 25. US & Canada Mental Disorders Drugs Sales YoY (2018-2029) & (K Units)
Figure 26. US & Canada Mental Disorders Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Europe Mental Disorders Drugs Sales YoY (2018-2029) & (K Units)
Figure 28. Europe Mental Disorders Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 29. China Mental Disorders Drugs Sales YoY (2018-2029) & (K Units)
Figure 30. China Mental Disorders Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 31. Asia (excluding China) Mental Disorders Drugs Sales YoY (2018-2029) & (K Units)
Figure 32. Asia (excluding China) Mental Disorders Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 33. Middle East, Africa and Latin America Mental Disorders Drugs Sales YoY (2018-2029) & (K Units)
Figure 34. Middle East, Africa and Latin America Mental Disorders Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 35. The Mental Disorders Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 36. The Top 5 and 10 Largest Manufacturers of Mental Disorders Drugs in the World: Market Share by Mental Disorders Drugs Revenue in 2022
Figure 37. Global Mental Disorders Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 38. Global Mental Disorders Drugs Sales Market Share by Type (2018-2029)
Figure 39. Global Mental Disorders Drugs Revenue Market Share by Type (2018-2029)
Figure 40. Global Mental Disorders Drugs Sales Market Share by Application (2018-2029)
Figure 41. Global Mental Disorders Drugs Revenue Market Share by Application (2018-2029)
Figure 42. US & Canada Mental Disorders Drugs Sales Market Share by Type (2018-2029)
Figure 43. US & Canada Mental Disorders Drugs Revenue Market Share by Type (2018-2029)
Figure 44. US & Canada Mental Disorders Drugs Sales Market Share by Application (2018-2029)
Figure 45. US & Canada Mental Disorders Drugs Revenue Market Share by Application (2018-2029)
Figure 46. US & Canada Mental Disorders Drugs Revenue Share by Country (2018-2029)
Figure 47. US & Canada Mental Disorders Drugs Sales Share by Country (2018-2029)
Figure 48. U.S. Mental Disorders Drugs Revenue (2018-2029) & (US$ Million)
Figure 49. Canada Mental Disorders Drugs Revenue (2018-2029) & (US$ Million)
Figure 50. Europe Mental Disorders Drugs Sales Market Share by Type (2018-2029)
Figure 51. Europe Mental Disorders Drugs Revenue Market Share by Type (2018-2029)
Figure 52. Europe Mental Disorders Drugs Sales Market Share by Application (2018-2029)
Figure 53. Europe Mental Disorders Drugs Revenue Market Share by Application (2018-2029)
Figure 54. Europe Mental Disorders Drugs Revenue Share by Country (2018-2029)
Figure 55. Europe Mental Disorders Drugs Sales Share by Country (2018-2029)
Figure 56. Germany Mental Disorders Drugs Revenue (2018-2029) & (US$ Million)
Figure 57. France Mental Disorders Drugs Revenue (2018-2029) & (US$ Million)
Figure 58. U.K. Mental Disorders Drugs Revenue (2018-2029) & (US$ Million)
Figure 59. Italy Mental Disorders Drugs Revenue (2018-2029) & (US$ Million)
Figure 60. Russia Mental Disorders Drugs Revenue (2018-2029) & (US$ Million)
Figure 61. China Mental Disorders Drugs Sales Market Share by Type (2018-2029)
Figure 62. China Mental Disorders Drugs Revenue Market Share by Type (2018-2029)
Figure 63. China Mental Disorders Drugs Sales Market Share by Application (2018-2029)
Figure 64. China Mental Disorders Drugs Revenue Market Share by Application (2018-2029)
Figure 65. Asia Mental Disorders Drugs Sales Market Share by Type (2018-2029)
Figure 66. Asia Mental Disorders Drugs Revenue Market Share by Type (2018-2029)
Figure 67. Asia Mental Disorders Drugs Sales Market Share by Application (2018-2029)
Figure 68. Asia Mental Disorders Drugs Revenue Market Share by Application (2018-2029)
Figure 69. Asia Mental Disorde